Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Anticancer Research

• Publication date

  1998-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9891473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies.

  1998cited by this paper
• Role of apoptosis, proliferating cell nuclear antigen and p53 protein in the immune response of rat colon cells to cancer and vaccination with anti-p53 polyclonal antibodies.

  1997cited by this paper
• Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus.

  1997cited by this paper
• The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors.

  1997cited by this paper
• Parenteral Gene Therapy with p53 Inhibits Human Breast Tumors In Vivo Through a Bystander Mechanism Without Evidence of Toxicity

  1997cited by this paper
• Apoptosis and cancer risk assessment.

  1996cited by this paper
• Exploring the mechanisms of primary antibody responses to T cell-dependent antigens.

  1996cited by this paper
• Functions of CD40 and its ligand, gp39 (CD40L).

  1996cited by this paper
• Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas.

  1996cited by this paper
• Cross‐reactive idiotypes on rabbit anti‐SEA antibodies stimulate anti‐idiotype spleen and lymph node cell responses of mice infected with Schistosoma mansoni

  1996cited by this paper
• Gene vaccination with naked plasmid DNA: mechanism of CTL priming

  1996cited by this paper
• Regulation of apoptosis by oncogenes

  1996cited by this paper
• High tumor-preventive effects of polyclonal IgG generated against p53 tumor-associated protein obtained from benign-tumor bearing rats.

  1996cited by this paper
• Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells.

  1996cited by this paper
• Mutational and LOH analyses of p53 alleles in colon tumors induced by 1,2-dimethylhydrazine in F1 hybrid mice.

  1995cited by this paper
• Cell cycle and apoptosis: Common pathways to life and death

  1995cited by this paper
• Isolation of tumor-associated protein from sera of colon tumor-bearing rats using polyclonal antibodies entrapped in gel fiberglass columns.

  1994cited by this paper
• Differentiation and cell death: lessons from the immune system.

  1994cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Functional anatomy of germinal centers.

  1984cited by this paper
• Aggressive behavior of squamous cell carcinoma in a patient with preceding lymphocytic lymphoma.

  1981cited by this paper

• Biological Therapy of Breast Cancer

  2012cites this paper
• The Soluble p 51 Protein in Cancer Diagnosis , Prevention and Therapy

  2009cites this paper
• The soluble p51 protein in cancer diagnosis, prevention and therapy.

  2005cites this paper
• Interaction between the immune system and tongue squamous cell carcinoma induced by 4-nitroquinoline N-oxide in mice.

  2004cites this paper
• Soluble tumor-associated antigens in cancer detection, prevention and therapy.

  2004cites this paper
• Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management.

  2002cites this paper
• Prophylactic cancer vaccines.

  2002cites this paper
• A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line.

  2002cites this paper
• Current concepts in cancer vaccine strategies.

  2001cites this paper
• Soluble low-molecular-mass tumor-associated proteins promote the suppression of mammary tumors by cyclophosphamide.

  2001cites this paper
• Effects of the soluble low-molecular-mass proteins on spleen activity and cellular composition of infiltrates in rat mammary gland tumors.

  2001cites this paper
• Soluble low-molecular-mass heat shock proteins and tumor-associated antigens in prevention and therapy of chemically-induced cancers.

  2001cites this paper
• Review Current Concepts in Cancer Vaccine Strategies

  2001cites this paper
• Vaccination with soluble low-molecular weight tumor-associated proteins suppresses chemically-induced mammary tumorigenesis in rats.

  2000cites this paper
• Skin cancer in liver transplant recipients

  2000cites this paper
• Vaccination with polyclonal non-tumor-specific IgG has no therapeutic effects on tumorigenic activity of hepatoma cells grafted to rats: experimental and biochemical studies.

  1999cites this paper
• Morphological and morphometric studies of the splenic antitumor immune response, elicited by liposome-covered soluble p53 kDa antigen, in chemically-induced rat colon cancer.

  1999cites this paper
• Transplacental tumor-preventive effects of polyclonal antibodies generated against the soluble 53 kDa antigen on mammary tumorigenesis in offspring.

  1999cites this paper